News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Siemens (SI) to Market BioPorto’s Breakthrough Kidney Test


12/11/2012 9:59:50 AM

Expectations for BioPorto Diagnostics have been high since the company launched its anticipated blockbuster product almost two years ago – the kidney injury test known as NGAL. Since then, BioPorto has worked towards solutions that would ensure broad and early market access to the test. In this regard, the first partnership on a global marketing level is now in place. This comes in the form of an informal sales partnership with Siemens Healthcare Diagnostics actively promoting BioPorto’s NGAL test, while the distribution still flows through BioPorto’s sales channels.

Read at GlobeNewswire


comments powered by Disqus
Siemens
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES